SENSEX NIFTY

Ranbaxy Laboratories

Jan 01, 2017 at 00:00 | Source: Moneycontrol.com
With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?
Dec 20, 2016 at 11:12 | Source: PTI
Drug major Sun Pharma today saidone of its subsidiaries has voluntarily requested the UShealth regulator to withdraw approval for 28 Abbreviated NewDrug Applications belonging to Ranbaxy Laboratories.
May 09, 2016 at 15:18 | Source: CNBC-TV18
Joint inspections with eight other regulators carried at six of Ranbaxys laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
May 05, 2016 at 20:47 | Source: CNBC-TV18
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
Apr 04, 2016 at 19:50 | Source: PTI
The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd forallegedly selling substandard drugs in India.
Mar 07, 2016 at 12:26 | Source: Reuters
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.
Jan 22, 2016 at 19:05 | Source: PTI
Last year in September, Sun Pharma and Strides Shasun (then Strides Arcolab) had inked a pact related to Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India.
Oct 28, 2015 at 20:15 | Source: PTI
As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Oct 09, 2015 at 08:36 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Limited (Ranbaxy) in November 2014 in a US District Court against U.S. Food and Drug Administration (FDA).
Messages on Ranbaxy Laboratories »

Sun Pharma  

Sun Pharma completed the acquisition of Ranbaxy Laboratories Limited, an integrated, research based, international pharmaceutical company, on 25th March 2015. .... After acquisition Sun Pharma is 5th largest Pharmacy Industry in the world.

4.53 PM Jan 16th

Wire News

Platinum Member

731 Followers

News Now  

Drug major Sun Pharma today said one of its subsidiaries has voluntarily requested the US health regulator to withdraw approval for 28 Abbreviated New Drug Applications belonging to Ranbaxy Laboratories.

11.12 AM Dec 20th 2016

manishshah3
73

New Member

8 Followers

Laurus Labs  

was featured on the cover page of September 2015 issue of Forbes India and our Company was recognized as one of the 13 hidden gems of India in that issue. During the last 23 years he has worked in various pharmaceutical companies including Ranbaxy Laboratories Limited, Vera Laboratories Limited and Vorin

10.30 AM Dec 6th 2016

hello1238

Platinum Member

543 Followers

Pantaloon Ret  

17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter lag

10.24 AM Jan 31st 2013

hello1238

Platinum Member

543 Followers

Ranbaxy Labs  

, from 17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter

10.23 AM Jan 31st 2013

BSE/NSE Announcer

Platinum Member

22587 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2013, inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended December 31, 2012.

5.05 PM Jan 29th 2013

Market Statistician

Platinum Member

21534 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 455.20 up 0.84%, with a huge increase in its volume of shares traded. Till now over 274,298 shares were traded as compared to its 5-day average of 115,221 shares.

3.15 PM Jan 25th 2013

usha91

New Member

1 Followers

Services - Sector  

Ranbaxy Laboratories

3.39 PM Jan 23rd 2013

vikraj

Gold Member

14 Followers

Jupiter Bio  

into a Confidentiality Agreement with M/s. Ranbaxy Laboratories Ltd to discuss business alliance. 13 Apr 2007 Jupiter Bioscience - Outcome of Board Meeting Jupiter Bioscience Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 12, 2007, inter alia, has decided

6.32 PM Jan 17th 2013

Web Messenger

Platinum Member

369120 Followers

Ranbaxy Labs  

Source:Economic Times - In a chat with ET Now, Deepak Mohoni, Director, trendwatchindia.com, shares his views on Ranbaxy Laboratories Ltd. ET Now: What is your call on Ranbaxy Laboratories Ltd? Deepak Mohoni: Sell Ranbaxy Labs at a stop loss of Rs 494 and a target of 478. It is a pure day trade.

4.28 PM Jan 17th 2013

News across the web »
Nov 07, 2015 at 02:30 | Source: FirstPost
Follow us on
Available On